Somatic tumor mutations in moderate risk cancer genes: Targets for germline confirmatory testing.

Llorin, Hannah; Graf, Madeline; Chun, Nicolette; Ford, James

Llorin, Hannah; Graf, Madeline; Chun, Nicolette; Ford, James.

Afiliación

Llorin H; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Graf M; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Chun N; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Ford J; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: jmf@stanford.edu.

Cancer Genet ; 268-269: 22-27, 2022 11.

Article en En | MEDLINE | ID: mdl-36116289

Asunto(s)

Neoplasias de la Mama; Neoplasias Ováricas; Adulto; Femenino; Humanos; Neoplasias de la Mama/diagnóstico; Neoplasias de la Mama/genética; Predisposición Genética a la Enfermedad; Pruebas Genéticas/métodos; Mutación de Línea Germinal; Oncogenes; Neoplasias Ováricas/diagnóstico; Neoplasias Ováricas/genética; Estudios Retrospectivos

Palabras clave

Cancer genetics; Cancer genomics; Germline; Somatic

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies Límite: Adult / Female / Humans Idioma: En Revista: Cancer Genet Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google